
OLD Category: immuno-oncology
September 3, 2021 / ESMO Open
Refining patient selection for breast cancer immunotherapy: beyond PD-L1
September 3, 2021 / ESMO Open
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma
September 3, 2021 / Cancer Discov
Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
August 31, 2021 / Nat Commun
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
August 30, 2021 / BMC Cancer
The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors
August 26, 2021 / Cell
Spatially organized multicellular immune hubs in human colorectal cancer
August 25, 2021 / Int J Mol Sci
MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models
August 20, 2021 / Cancer Immunol Immunother
Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma
August 18, 2021 / Oncoimmunology
PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinoma
August 17, 2021 / Cancer Treat Res